These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 8734135)

  • 21. [Deep venous thrombosis on implantable infusion devices. A prospective study of 72 patients with Doppler ultrasonography of veins of the neck (jugular, subclavian and brachiocephalic trunk)].
    Pucheu A; Leduc B; Sillet-Bach I; Payen C; Pucheu ME
    Bull Cancer; 1993 Aug; 80(8):680-8. PubMed ID: 8204948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protocols on thrombosis and hemostasis in clinical practice].
    Crespo FF
    Acta Med Port; 1994 Jan; 7(1):61-3. PubMed ID: 8184728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should thromboprophylactic dosage of low molecular weight heparin be adapted to patient's weight?
    Vitoux JF; Aiach M; Roncato M; Fiessinger JN
    Thromb Haemost; 1988 Feb; 59(1):120. PubMed ID: 3363527
    [No Abstract]   [Full Text] [Related]  

  • 24. [Outcome of usage protocols on implantable devices].
    Theard JL; Robard S
    Ann Fr Anesth Reanim; 1995; 14(6):534-5. PubMed ID: 8745984
    [No Abstract]   [Full Text] [Related]  

  • 25. [Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis].
    Pucheu A; Dierhas M; Leduc B; Sillet-Bach I; Lefort S; Assaf W; Pucheu M
    Bull Cancer; 1996 Apr; 83(4):293-9. PubMed ID: 8680080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep vein thrombosis].
    Moreno-Palomares JJ; Fisac-Herrero RM; Herrero-Domingo A; Ferreira-Pasos EM; Grasa J; Reverte-Cejudo D
    An Med Interna; 2001 Jul; 18(7):364-8. PubMed ID: 11534421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
    Labas P; Ohrádka B; Vladimír J; Cambal M
    Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental prevention of deep venous thrombosis with low-molecular-weight heparin using implantable infusion devices].
    Pucheu A; Leduc B; Sillet-Bach I; Payen C; Assaf W; Pucheu M
    Ann Cardiol Angeiol (Paris); 1996 Feb; 45(2):59-63. PubMed ID: 8734135
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.